PL2788472T3 - Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki - Google Patents

Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki

Info

Publication number
PL2788472T3
PL2788472T3 PL12856068T PL12856068T PL2788472T3 PL 2788472 T3 PL2788472 T3 PL 2788472T3 PL 12856068 T PL12856068 T PL 12856068T PL 12856068 T PL12856068 T PL 12856068T PL 2788472 T3 PL2788472 T3 PL 2788472T3
Authority
PL
Poland
Prior art keywords
endothelial cells
corneal endothelial
directed differentiation
producing corneal
differentiation producing
Prior art date
Application number
PL12856068T
Other languages
English (en)
Inventor
Kathryn L. Mccabe
Shi-Jiang Lu
Robert Lanza
Original Assignee
Astellas Institute For Regenerative Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Institute For Regenerative Medicine filed Critical Astellas Institute For Regenerative Medicine
Publication of PL2788472T3 publication Critical patent/PL2788472T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/08—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL12856068T 2011-12-06 2012-12-06 Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki PL2788472T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161567479P 2011-12-06 2011-12-06
EP12856068.7A EP2788472B1 (en) 2011-12-06 2012-12-06 Method of directed differentiation producing corneal endothelial cells
PCT/US2012/068305 WO2013086236A2 (en) 2011-12-06 2012-12-06 Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof

Publications (1)

Publication Number Publication Date
PL2788472T3 true PL2788472T3 (pl) 2019-06-28

Family

ID=48575057

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12856068T PL2788472T3 (pl) 2011-12-06 2012-12-06 Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki

Country Status (15)

Country Link
US (3) US9752118B2 (pl)
EP (2) EP2788472B1 (pl)
CA (2) CA3178138A1 (pl)
CY (1) CY1121383T1 (pl)
DK (1) DK2788472T3 (pl)
ES (1) ES2716200T3 (pl)
HR (1) HRP20190460T1 (pl)
HU (1) HUE041929T2 (pl)
LT (1) LT2788472T (pl)
PL (1) PL2788472T3 (pl)
PT (1) PT2788472T (pl)
RS (1) RS58526B1 (pl)
SI (1) SI2788472T1 (pl)
TR (1) TR201903889T4 (pl)
WO (1) WO2013086236A2 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842669B2 (en) * 2008-11-13 2020-11-24 Gholam A. Peyman Ophthalmic drug delivery method
PL2788472T3 (pl) 2011-12-06 2019-06-28 Astellas Institute For Regenerative Medicine Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki
EP2876160B1 (en) * 2012-07-06 2020-05-13 Kyoto Prefectural Public University Corporation Differentiation marker for and differentiation control for ocular cells
WO2014179716A2 (en) * 2013-05-03 2014-11-06 Emmetrope Ophthalmics Llc IDENTIFICATION AND ISOLATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCECs)
MX386503B (es) 2013-07-30 2025-03-19 Kyoto Prefectural Public Univ Corp Medicamentos terapeuticos de matriz extracelular endotelial corneal.
EP3029140A4 (en) 2013-07-30 2017-06-28 Kyoto Prefectural Public University Corporation Corneal endothelial cell marker
SG11201600813VA (en) 2013-08-06 2016-03-30 Riken Method for producing anterior eye segment tissue
WO2015041606A1 (en) * 2013-09-17 2015-03-26 Singapore Health Services Pte Ltd Corneal stromal keratocyte culture
CA2927898C (en) 2013-10-31 2021-11-16 Kyoto Prefectural Public University Corporation Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
ES2763433T3 (es) * 2013-11-27 2020-05-28 Kyoto Prefectural Public Univ Corp Aplicación de laminina a cultivos de células endoteliales de la córnea
MX387839B (es) * 2014-10-31 2025-03-04 Senju Pharma Co Laminina para usarse en el tratamiento de una enfermedad, un trastorno o una afección de un endotelio de córnea.
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
CA2980580C (en) 2015-03-23 2024-01-23 Astellas Institute For Regenerative Medicine Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors
WO2017031312A1 (en) 2015-08-18 2017-02-23 Astellas Institute For Regenerative Medicine Clinical formulations
WO2017043604A1 (ja) 2015-09-08 2017-03-16 大日本住友製薬株式会社 網膜組織の製造方法
WO2017190136A1 (en) * 2016-04-29 2017-11-02 The Regents Of The University Of California Induction of corneal endothelial cells
WO2018187428A1 (en) * 2017-04-04 2018-10-11 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College A modified cell culture medium and uses thereof
US11433090B2 (en) 2017-06-16 2022-09-06 The Doshisha mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof
EP3639855A4 (en) * 2017-06-16 2021-03-17 The Doshisha COMPOUNDS HAVING CASPASE INHIBITORING ACTIVITY, PHARMACEUTICAL AGENT CONTAINING THEM FOR THE TREATMENT OR PREVENTION OF SYMPTOMS, DISORDERS OR DISEASES OF CORNEAL ENDOTHELIUM, AND APPLICATION OF SUCH PHARMACEUTICAL AGENT
CN107475200B (zh) * 2017-08-08 2020-12-22 浙江大学 一种背根神经节源的神经嵴干细胞的分离、培养与分化方法
KR102010478B1 (ko) * 2017-11-01 2019-08-13 차의과학대학교 산학협력단 줄기 세포의 신경 능선 세포로의 분화용 조성물, 키트, 및 이를 이용한 방법
SG11202004831QA (en) * 2017-11-24 2020-06-29 Sumitomo Chemical Co Production method for cell mass including neural cells/tissue and non-neural epithelial tissue, and cell mass from same
US12350294B2 (en) * 2018-01-16 2025-07-08 Keio University Medium comprising serum replacement, IGF1, STAT3 activator and adrenal gland hormone without BFGF or rock inhibitor for producing corneal endothelial substitute cells from iPS cells and a method thereof
KR102114787B1 (ko) * 2018-04-02 2020-05-26 중앙대학교 산학협력단 리보핵산분해효소 5 고발현된 각막 내피세포를 포함하는 3차원 각막 내피 이식체 제조방법
US12553027B2 (en) * 2018-12-12 2026-02-17 The Johns Hopkins University Generation and cryopreservation of pluripotent stem cell-derived clinical grade corneal endothelial cells
US20220145264A1 (en) * 2019-04-05 2022-05-12 The University Of Hong Kong Culture medium for mammalian expanded potential stem cells, composition, and methods thereof
KR102446567B1 (ko) * 2019-04-17 2022-09-26 연세대학교 산학협력단 각막 내피 세포의 기능 부전 진단용 바이오마커
MX2023013079A (es) 2021-05-03 2023-11-16 Astellas Inst For Regenerative Medicine Metodos de generacion de celulas maduras del endotelio corneal.
CN113355424B (zh) * 2021-07-14 2022-03-25 江苏先声医学诊断有限公司 Pcdh11x突变在预测非小细胞肺癌患者对免疫检查点抑制剂疗法敏感性中的应用
CN117736990B (zh) * 2022-09-13 2025-10-24 中国科学院动物研究所 一种实现细胞分化的体外培养法以及由此得到的细胞群及其用途
EP4636079A1 (en) * 2022-12-13 2025-10-22 The Asan Foundation Method for inducing differentiation of stem cells into corneal endothelial cells and use thereof
KR20250141827A (ko) * 2023-02-10 2025-09-29 알데브론 엘엘씨 눈 앞부분을 위한 유전자 요법
WO2024210619A1 (ko) * 2023-04-06 2024-10-10 재단법인 아산사회복지재단 줄기세포의 각막 내피 세포로의 직접 분화 유도용 조성물 및 이를 이용한 직접 분화 유도 방법
CN116966105B (zh) * 2023-04-20 2025-12-19 合肥核信生物科技有限责任公司 促进皮肤细胞胶原蛋白生成的小分子及其应用
WO2025100401A1 (ja) * 2023-11-06 2025-05-15 国立大学法人大阪大学 角膜内皮細胞の製造方法

Family Cites Families (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3421217A (en) 1967-06-29 1969-01-14 Schick Electric Inc Hair receptacle for electric shaver
US5166048A (en) 1981-03-02 1992-11-24 Soll David B Protection of human corneal endothelial cells
US4678783B1 (en) 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
US4959319A (en) 1985-08-01 1990-09-25 Skelnik Debra L Process of corneal enhancement
US5269812A (en) 1986-05-16 1993-12-14 White Thomas C Methods and devices employed in replacement of the corneal endothelium
AU8532691A (en) 1990-08-01 1992-03-02 Chiron Ophthalmics Inc. Method for treating corneal endothelial wounds
US5589451A (en) 1992-09-21 1996-12-31 Board Of Regents, The University Of Texas System Methods and treaments for corneal healing with hepatocyte and keratinocyte growth factors
US5703047A (en) 1992-09-21 1997-12-30 Board Of Regents, The University Of Texas System Methods and treatments for corneal healing with growth factors
US5755785A (en) 1994-08-12 1998-05-26 The University Of South Florida Sutureless corneal transplantation method
US5584881A (en) 1994-08-12 1996-12-17 Rowsey; J. James Sutureless corneal transplantation apparatus and method
US5649944A (en) 1994-08-12 1997-07-22 Collins; Joseph Patrick Apparatus for preparing cornea material for tabbed (sutureless) transplantation
US5686414A (en) 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
AU5734998A (en) 1997-01-10 1998-08-03 Life Technologies, Inc. Embryonic stem cell serum replacement
WO1999020620A1 (en) 1997-10-22 1999-04-29 Nippon Shinyaku Co Ltd Isoquinoline derivative and drug
ATE324362T1 (de) 1998-05-25 2006-05-15 Santen Pharmaceutical Co Ltd Neue vinylbenzolderivate
WO2000047040A1 (en) 1999-02-11 2000-08-17 The Schepens Eye Research Institute, Inc. Growth medium for human corneal endothelial cells
US6548059B1 (en) 1999-07-22 2003-04-15 The Schepens Eye Research Institute, Inc. Promotion of proliferation of adult corneal endothelial cells
AUPR069500A0 (en) * 2000-10-11 2000-11-09 Coster, Douglas John Tissue modification
TWI261055B (en) 2001-03-23 2006-09-01 Bayer Corp Rho-Kinase Inhibitors
PE20020958A1 (es) 2001-03-23 2002-11-14 Bayer Corp Inhibidores de la rho-quinasa
US7199147B2 (en) 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
CA2472619A1 (en) 2002-01-10 2003-07-24 Bayer Corporation Fused pyrimidine derivates as rho-kinase inhibitors
MXPA04007196A (es) 2002-01-23 2005-06-08 Bayer Pharmaceuticals Corp Inhibidores de rho-quinasa.
CA2483659A1 (en) 2002-04-30 2003-11-13 Amniotec Inc. Corneal endothelium-like sheet and method of constructing the same
AU2003281623B8 (en) 2002-07-22 2009-06-11 Asahi Kasei Pharma Corporation 5-substituted isoquinoline derivative
DE10237945A1 (de) 2002-08-20 2004-03-11 Quintis Gmbh Laserbasierte Vorrichtung zur nichtmechanischen, dreidimensionalen Trepanation bei Hornhauttransplantationen
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
AU2003207288A1 (en) 2003-02-06 2004-08-30 Cellseed Inc. Anterior ocular-associated cell sheet, three-dimensional construct and process for producing the same
US9981064B2 (en) 2003-02-20 2018-05-29 Cellseed Inc. Regenerated corneal endothelial cell sheets, processes for producing the same, and methods of using the same
US7300654B2 (en) 2003-05-28 2007-11-27 Regeneron Pharmaceuticals, Inc. Method of treating corneal transplant rejection in high risk keratoplasty patients
CA2519835A1 (en) 2003-05-28 2004-12-09 Regeneron Pharmaceuticals, Inc. Method of treating corneal transplant rejection
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
EP1644365A2 (en) 2003-07-02 2006-04-12 Biofocus Discovery Ltd Pyrazine and pyridine derivatives as rho kinase inhibitors
US7147648B2 (en) 2003-07-08 2006-12-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Device for cutting and holding a cornea during a transplant procedure
WO2005039564A1 (en) 2003-10-02 2005-05-06 Vertex Pharmaceuticals Incorporated Phthalimide compounds useful as protein kinase inhibitors
WO2005037197A2 (en) 2003-10-06 2005-04-28 Glaxo Group Limited Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
JP2007507547A (ja) 2003-10-06 2007-03-29 グラクソ　グループ　リミテッド キナーゼ阻害剤としての１，７−二置換アザベンゾイミダゾールの調製
JP2007507549A (ja) 2003-10-06 2007-03-29 グラクソ　グループ　リミテッド キナーゼ阻害剤としての１，６，７−三置換アザベンゾイミダゾールの調製
WO2005037144A2 (en) 2003-10-10 2005-04-28 Cellular Bioengineering, Inc. Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
KR20070053152A (ko) 2003-10-10 2007-05-23 셀룰라 바이오엔지니어링 인코포레이티드 인간의 각막 내피세포 및 각막세포 이식을 위한 세포배양및 수득방법
US7563906B2 (en) 2003-10-15 2009-07-21 Ube Industries, Ltd. Indazole derivatives
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
US7087369B2 (en) 2003-12-17 2006-08-08 The Regents Of The University Of California Cornea preservation medium
JP4834802B2 (ja) 2004-02-18 2011-12-14 聡 山上 ヒト角膜内皮細胞の培養物層積層体及びその作製方法
EP1720874A4 (en) 2004-02-24 2010-03-03 Bioaxone Therapeutique Inc 4-SUBSTITUTED PIPERIDINE DERIVATIVES
US20060216821A1 (en) * 2004-02-26 2006-09-28 Reliance Life Sciences Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
TW200604168A (en) 2004-04-02 2006-02-01 Vertex Pharma Azaindoles useful as inhibitors of rock and other protein kinases
JP2006006249A (ja) * 2004-06-28 2006-01-12 Hiroshima Univ 羊膜由来細胞の培養方法及びその利用
US20060068496A1 (en) * 2004-07-29 2006-03-30 Kelly James H Differentiation of stem cells
JPWO2006057270A1 (ja) 2004-11-26 2008-06-05 旭化成ファーマ株式会社 含窒素３環化合物
WO2006092894A1 (ja) 2004-12-09 2006-09-08 Shiro Amano ヒト角膜内皮細胞由来の前駆細胞、細胞凝集体及びそれら作製方法、並びに前駆細胞および細胞凝集体の移植方法
US9999497B2 (en) 2005-01-31 2018-06-19 Yichieh Shiuey Corneal implants and methods and systems for placement
EP1868430B1 (en) 2005-04-12 2015-07-08 Cleo Cosmetic and Pharmaceutical Co., LLC Composition and method for in vitro preservation of corneal tissues
AU2006285915B2 (en) 2005-08-30 2011-02-24 Asahi Kasei Pharma Corporation Sulfonamide compound
WO2007047425A1 (en) 2005-10-12 2007-04-26 Cellular Bioengineering, Inc. Resorbable cornea button
US20070128722A1 (en) * 2005-12-05 2007-06-07 Industrial Technology Research Institute Human mesenchymal stem cells and culturing methods thereof
JP5255846B2 (ja) 2006-01-19 2013-08-07 千寿製薬株式会社 生体内で細胞増殖可能な角膜内皮製剤
TWI407967B (zh) * 2006-04-28 2013-09-11 Ray Jui Fang Tsai 人類角膜內皮幹細胞之擴增方法
EP2484308A1 (en) 2006-07-24 2012-08-08 International Stem Cell Corporation Synthetic cornea from retinal stem cells
US20080050423A1 (en) 2006-08-23 2008-02-28 National Tsing Hua University Biopolymer-bioengineered cell sheet construct
EP2066334B1 (en) * 2006-09-28 2016-04-06 TissueTech, Inc. Rnai methods and compositions for stimulating proliferation of cells with adherent junctions
US20100022517A1 (en) * 2006-12-18 2010-01-28 Richards Lori A Ophthalmic formulation of rho kinase inhibitor compound
US8071779B2 (en) * 2006-12-18 2011-12-06 Inspire Pharmaceuticals, Inc. Cytoskeletal active rho kinase inhibitor compounds, composition and use
WO2009011139A1 (ja) * 2007-07-13 2009-01-22 Mitsubishi Tanabe Pharma Corporation 細胞の単離方法、細胞用無血清培養培地および細胞の培養方法
KR101617243B1 (ko) * 2007-07-31 2016-05-02 라이프스캔, 인코포레이티드 인간 배아 줄기 세포의 분화
JPWO2009028632A1 (ja) 2007-08-28 2010-12-02 東芝キヤリア株式会社 ロータリ式圧縮機及び冷凍サイクル装置
KR20220151013A (ko) 2007-08-29 2022-11-11 센주 세이야꾸 가부시키가이샤 각막 내피 세포 접착 촉진제
US20100297234A1 (en) * 2007-10-19 2010-11-25 Ilene Sugino Method of using an extracellular matrix to enhance cell transplant survival and differentiation
WO2009058958A2 (en) 2007-10-30 2009-05-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Lipoxin a4 protection for cornea endothelial cells
EP2280676A2 (en) 2008-04-25 2011-02-09 The Regents of the University of California Device to store and inject corneal graft
JP5305066B2 (ja) * 2008-05-09 2013-10-02 国立大学法人大阪大学 組織幹細胞／組織前駆細胞からの角膜内皮細胞の生成方法
US20100184033A1 (en) * 2008-07-16 2010-07-22 West Michael D Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
WO2008155748A2 (en) 2008-09-04 2008-12-24 Massimo Busin A new technique for preparing, storing and transplanting endothelial grafts
EP2383334A4 (en) * 2009-01-23 2013-01-16 Univ Osaka FEEDER CELL FOR TARGET CELL INDUCTION
WO2010096496A2 (en) 2009-02-17 2010-08-26 Memorial Sloan-Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
WO2010099310A1 (en) 2009-02-26 2010-09-02 Wake Forest University Health Sciences Endothelial scaffolds
WO2010108126A2 (en) * 2009-03-19 2010-09-23 Fate Therapeutics, Inc. Reprogramming compositions and methods of using the same
JP5700301B2 (ja) 2009-06-03 2015-04-15 国立大学法人大阪大学 多能性幹細胞からの神経堤細胞群の分化誘導方法
US20120282318A1 (en) * 2009-08-19 2012-11-08 Koyoto University Sheet for corneal transplants
WO2011041062A1 (en) 2009-10-02 2011-04-07 University Of Southern California Cranial neural crest stem cells and culture condition that supports their growth
US20110143415A1 (en) * 2009-12-14 2011-06-16 Sergei Paylian Reprogramming normal and cancerous human cell lines into human induced poluripotent stem cells by co-electroporation with living xenopus laevis frog oocytes
WO2011080984A1 (en) * 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
US9376661B2 (en) * 2010-02-05 2016-06-28 Cornea Regeneration Institute Co., Ltd. Method for culture of corneal endothelial cells, process for production of corneal endothelial cell sheet for transplantation purposes, and culture kit for corneal endothelial cells
WO2011142364A1 (ja) * 2010-05-10 2011-11-17 独立行政法人理化学研究所 細胞シート作製方法
PT2577318T (pt) * 2010-05-25 2019-10-14 Memorial Sloan Kettering Cancer Center Método de diferenciação de nocicetor de células estaminais embrionárias humanas e utilizações do mesmo
WO2012012803A2 (en) * 2010-07-23 2012-01-26 Advanced Cell Technology, Inc. Methods for detection of rare subpopulations of cells and highly purified compositions of cells
US20120028933A1 (en) * 2010-07-28 2012-02-02 Baust John M Cell Culture Media Supplement and Method of Molecular Stress Control
WO2012135621A2 (en) 2011-03-30 2012-10-04 Cellular Dynamics International. Inc Priming of pluripotent stem cells for neural differentiation
JP5761827B2 (ja) * 2011-07-15 2015-08-12 国立大学法人大阪大学 角膜内皮細胞の調製方法
EP2765188B1 (en) 2011-10-06 2017-12-06 Keio University Method for producing corneal endothelial cell
PL2788472T3 (pl) 2011-12-06 2019-06-28 Astellas Institute For Regenerative Medicine Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki
ES2917222T3 (es) 2011-12-28 2022-07-07 Kyoto Prefectural Public Univ Corp Normalización del cultivo de células endoteliales de la córnea
EP2876160B1 (en) 2012-07-06 2020-05-13 Kyoto Prefectural Public University Corporation Differentiation marker for and differentiation control for ocular cells
US20140314723A1 (en) * 2013-04-17 2014-10-23 National University Of Singapore Endothelial cell culture
WO2014179716A2 (en) 2013-05-03 2014-11-06 Emmetrope Ophthalmics Llc IDENTIFICATION AND ISOLATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCECs)
EP3029140A4 (en) 2013-07-30 2017-06-28 Kyoto Prefectural Public University Corporation Corneal endothelial cell marker
ES2763433T3 (es) 2013-11-27 2020-05-28 Kyoto Prefectural Public Univ Corp Aplicación de laminina a cultivos de células endoteliales de la córnea
SG11201608489VA (en) 2014-04-11 2016-11-29 Agency Science Tech & Res Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody
EP3190181B1 (en) 2014-09-05 2020-06-17 Osaka University Corneal endothelial cell marker
WO2016093359A1 (ja) 2014-12-11 2016-06-16 学校法人慶應義塾 治療用角膜内皮代替細胞スフェアの製造方法
SG11201705750WA (en) 2015-01-15 2017-08-30 Univ Osaka Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells
WO2016129654A1 (ja) 2015-02-12 2016-08-18 国立大学法人 東京大学 角膜内皮前駆細胞の調製方法
DE102015205534B4 (de) 2015-03-26 2017-01-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Artifizielles Descemet-Konstrukt
EP4218773A1 (en) 2016-02-15 2023-08-02 Kyoto Prefectural Public University Corporation Human functional corneal endothelial cell and application thereof
WO2017190136A1 (en) 2016-04-29 2017-11-02 The Regents Of The University Of California Induction of corneal endothelial cells
WO2018044809A1 (en) 2016-08-29 2018-03-08 Hackensack University Medical Center Compositions and methods for reprogramming adult cells through the stemness of a platelet rich fraction of blood containing platelet-like cells in humans
KR102396303B1 (ko) 2016-08-29 2022-05-09 해컨색 유니버시티 메디컬 센터 혈소판-유사 세포를 함유하는 혈액의 혈소판 풍부 분획을 이용하여 성체 세포를 재프로그래밍하기 위한 조성물 및 방법
WO2018143312A1 (ja) 2017-01-31 2018-08-09 国立大学法人大阪大学 多能性幹細胞の分化制御方法
US20200063105A1 (en) 2017-05-01 2020-02-27 President And Fellows Of Harvard College Transcription factors controlling differentiation of stem cells
JP6758631B2 (ja) 2017-06-19 2020-09-23 国立大学法人大阪大学 角膜内皮細胞マーカー及びその利用
TWI820034B (zh) 2017-07-31 2023-11-01 香港商映像生物有限公司 眼部疾病之細胞模式及用於眼部疾病的療法
US12350294B2 (en) 2018-01-16 2025-07-08 Keio University Medium comprising serum replacement, IGF1, STAT3 activator and adrenal gland hormone without BFGF or rock inhibitor for producing corneal endothelial substitute cells from iPS cells and a method thereof
WO2019198086A1 (en) 2018-04-11 2019-10-17 Precise Bio Inc Bioengineered corneal graft and methods of preparation thereof
CA3103823A1 (en) 2018-06-14 2019-12-19 Figene, Llc Use of fibroblasts and/or modified fibroblasts for three dimensional tissue printing
JP7340863B2 (ja) 2018-06-29 2023-09-08 学校法人同志社 エムリカサンを含む製剤
CN113056556A (zh) 2018-08-31 2021-06-29 学校法人同志社 用于对眼细胞进行保存或培养的组合物以及方法
WO2020071438A1 (ja) 2018-10-02 2020-04-09 学校法人同志社 角膜内皮細胞を保存するための方法および容器
MX2023013079A (es) 2021-05-03 2023-11-16 Astellas Inst For Regenerative Medicine Metodos de generacion de celulas maduras del endotelio corneal.

Also Published As

Publication number Publication date
US20240409892A1 (en) 2024-12-12
EP2788472B1 (en) 2019-02-20
CA2858173A1 (en) 2013-06-13
RS58526B1 (sr) 2019-04-30
CA2858173C (en) 2023-09-26
SI2788472T1 (sl) 2019-04-30
WO2013086236A3 (en) 2013-08-01
LT2788472T (lt) 2019-04-10
CY1121383T1 (el) 2020-05-29
EP2788472A2 (en) 2014-10-15
US9752118B2 (en) 2017-09-05
US12049642B2 (en) 2024-07-30
US20140370007A1 (en) 2014-12-18
CA3178138A1 (en) 2013-06-13
WO2013086236A2 (en) 2013-06-13
HUE041929T2 (hu) 2019-06-28
DK2788472T3 (en) 2019-04-08
PT2788472T (pt) 2019-04-01
ES2716200T3 (es) 2019-06-11
US20180072989A1 (en) 2018-03-15
EP3517604A1 (en) 2019-07-31
HRP20190460T1 (hr) 2019-04-19
TR201903889T4 (tr) 2019-04-22
EP2788472A4 (en) 2015-07-29

Similar Documents

Publication Publication Date Title
PL2788472T3 (pl) Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki
EP2765188A4 (en) METHOD FOR THE PRODUCTION OF HORN-HAUTENDOTHELIC CELLS
PL3287110T3 (pl) Sposób wytwarzania struktur chłonnych do wyrobów chłonnych
IL227879A0 (en) A method for producing an optically active dihydrobenzofuran derivative
IL225628A0 (en) Differentiation methods for the production of glial cell populations
SG11201404677TA (en) Process of expanding t cells
ZA201400196B (en) Method of producing nanoparticles
IL228087A0 (en) A method for producing a retinal pigment epithelial cell area
PL2766489T3 (pl) Metoda produkcji produktów na bazie drobnoustrojów
EP2729561A4 (en) CELL CULTURE METHOD
GB2491256B (en) Method of making a treated super-hard structure
PL2776455T3 (pl) Rodopsyny kanałowe do kontroli optycznej komórek
SG11201401282PA (en) Process for the production of estetrol
GB201110042D0 (en) Growth of cells
HUE039606T2 (hu) Mesterséges szem elõállítása
EP2687544A4 (en) PROCESS FOR THE PRODUCTION OF MODIFIED HYDROPHILIC POLYROTAXANE
PT2925856T (pt) Métodos de produção de células epr
GB2520899B (en) Method for discriminating differentiation degree of pluripotent stem cell
TWI563093B (en) Method of producing isopropyl alcohol by continuous culture
SG11201400287XA (en) Methods for producing biocompatible materials
SG11201403485VA (en) Method of Forming Boding Structure
SG2014005623A (en) Method for producing alpha-hydroxycarboxylic acid esters
PL2675555T3 (pl) Sposób wytwarzania i analizy prionów
SG11201500386WA (en) Cell culture of corneal endothelial cells
SG11201401492RA (en) Process for making esters